Paul B. Knight
Directeur/Membre du Conseil chez Molecular Diagnostics & Therapeutics, Inc.
Profil
Paul B.
Knight has been a Director of Molecular Diagnostics & Therapeutics, Inc. since August 2000.
He is President of Transwestern Financial Advisors.
Mr. Knight has experience in capital management, financial forecasting, preparation of financial statements, and overseeing SEC filings and requirements
Postes actifs de Paul B. Knight
| Sociétés | Poste | Début |
|---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
 Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Directeur/Membre du Conseil | 01/08/2000 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Molecular Diagnostics & Therapeutics, Inc.
Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |
